trexject in methotrexate (as sodium) 20mg/0.40ml solution for injection pre-filled syringe
link medical products pty ltd t/a link pharmaceuticals - methotrexate -
trexject in methotrexate (as sodium) 17.5mg/0.35ml solution for injection pre-filled syringe
link medical products pty ltd t/a link pharmaceuticals - methotrexate -
trexject in methotrexate (as sodium) 15mg/0.30ml solution for injection pre-filled syringe
link medical products pty ltd t/a link pharmaceuticals - methotrexate -
trexject in methotrexate (as sodium) 12.5mg/0.25ml solution for injection pre-filled syringe
link medical products pty ltd t/a link pharmaceuticals - methotrexate -
trexject in methotrexate (as sodium) 10mg/0.20ml solution for injection pre-filled syringe
link medical products pty ltd t/a link pharmaceuticals - methotrexate -
trexject in methotrexate (as sodium) 7.5mg/0.15ml solution for injection pre-filled syringe
link medical products pty ltd t/a link pharmaceuticals - methotrexate -
micanol dithranol 1% cream tube
link medical products pty ltd t/a link pharmaceuticals - dithranol -
trasylol aprotinin 1,000,000 kiu/100ml
link medical products pty ltd t/a link pharmaceuticals - aprotinin, quantity: 10000 kiu/ml - injection, intravenous infusion - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - trasylol is used prophylactically to reduce perioperative blood loss and to reduce the need for blood transfusion in adult patients undergoing cardiopulmonary bypass in the course of coronary artery bypass graft surgery, where the risk of bleeding is high (impaired haemostasis, eg. presence of aspirin) or where transfusion is unavailable or unacceptable.
trasylol 2,000,000 kiu/200ml
link medical products pty ltd t/a link pharmaceuticals - aprotinin, quantity: 10000 kiu/ml - injection, intravenous infusion - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - trasylol is used prophylactically to reduce perioperative blood loss and to reduce the need for blood transfusion in adult patients undergoing cardiopulmonary bypass in the course of coronary artery bypass graft surgery, where the risk of bleeding is high (impaired haemostasis, eg. presence of aspirin) or where transfusion is unavailable or unacceptable.
trasylol 500,000kiu/50ml injection vial
link medical products pty ltd t/a link pharmaceuticals - aprotinin, quantity: 10000 kiu/ml - injection, intravenous infusion - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - trasylol is used prophylactically to reduce perioperative blood loss and to reduce the need for blood transfusion in adult patients undergoing cardiopulmonary bypass in the course of coronary artery bypass graft surgery, where the risk of bleeding is high (impaired haemostasis, eg. presence of aspirin) or where transfusion is unavailable or unacceptable.